We explored global histone modifications during TGF-β1-induced EMT in two non-small cell lung cancer (NSCLC) cell lines and tested different epigenetic treatment to modulate or partially reverse EMT. This evidence concerns the gene TGFB1 and non-small cell lung carcinoma.